136 related articles for article (PubMed ID: 16463769)
21. Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter?
Vermeulen F; Proesmans M; Feyaerts N; De Boeck K
Pediatr Pulmonol; 2011 Feb; 46(2):145-52. PubMed ID: 20865746
[TBL] [Abstract][Full Text] [Related]
22. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
[TBL] [Abstract][Full Text] [Related]
24. CFTR is involved in membrane endocytosis but not in fluid-phase and receptor-mediated endocytosis in human respiratory epithelial cells.
Spilmont C; Hinnrasky J; Zahm JM; Jacquot J; Puchelle E; Kuhry JG
Biochem Biophys Res Commun; 1996 Oct; 227(1):182-8. PubMed ID: 8858122
[TBL] [Abstract][Full Text] [Related]
25. [Expression of tenascin in human nasal polyp tissue and primary studies of its clinical significance].
Sun G; Kong W; Li P; Xu X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):279-80. PubMed ID: 12916355
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of chloride channel ClC-2 and ClC-3 in human nasal polyps].
Li H; Han D; Zhou B; Fan E; Liu Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):266-7. PubMed ID: 12916350
[TBL] [Abstract][Full Text] [Related]
27. Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps.
Linke R; Pries R; Könnecke M; Bruchhage KL; Böscke R; Gebhard M; Wollenberg B
Int Arch Allergy Immunol; 2013; 162(4):290-8. PubMed ID: 24157808
[TBL] [Abstract][Full Text] [Related]
28. [The significance of microvessel density and CD34 expression in nasal polyps].
Yao L; Li X; Lu X; Yin W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Oct; 19(20):913-5. PubMed ID: 16398042
[TBL] [Abstract][Full Text] [Related]
29. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
30. The cystic fibrosis conductance regulator gene exon sequence is normal in a patient with edematous eosinophilic nasal polyps.
Bucholtz GA; Ejercito VS; Burmester JK
Am J Rhinol; 1999; 13(3):221-3. PubMed ID: 10392242
[TBL] [Abstract][Full Text] [Related]
31. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
[TBL] [Abstract][Full Text] [Related]
32. [Expression and distribution of Aquaporin 1 in the nasal polyps].
Guan G; Xu C; Dong Z; She C; Liu T; Jiang S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):330-2. PubMed ID: 12761937
[TBL] [Abstract][Full Text] [Related]
33. Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.
Xu R; Li Y; Xie M; Xu G; Zhang G; Wang S
Chin Med J (Engl); 2002 Sep; 115(9):1386-9. PubMed ID: 12411119
[TBL] [Abstract][Full Text] [Related]
34. Expression of guanylin and uroguanylin mRNA in human nasal mucosa and nasal polyps.
Lee SH; Paeng JP; Jung HH; Lee SH; Lee HM; Kwon SY; Lim KJ; Jung KY
Acta Otolaryngol; 2004 Mar; 124(2):179-85. PubMed ID: 15072421
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of cystic fibrosis transmembrane conductance regulator in human fetal airway and digestive mucosa.
Gaillard D; Ruocco S; Lallemand A; Dalemans W; Hinnrasky J; Puchelle E
Pediatr Res; 1994 Aug; 36(2):137-43. PubMed ID: 7526324
[TBL] [Abstract][Full Text] [Related]
36. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells.
Dray-Charier N; Paul A; Veissiere D; Mergey M; Scoazec JY; Capeau J; Brahimi-Horn C; Housset C
Lab Invest; 1995 Dec; 73(6):828-36. PubMed ID: 8558844
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
[TBL] [Abstract][Full Text] [Related]
38. [The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues].
Lu X; Liu Z; Cui Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):633-5. PubMed ID: 16248458
[TBL] [Abstract][Full Text] [Related]
39. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
40. Expression of hypoxia-inducible factor 1alpha in the nasal polyps by real-time RT-PCR and immunohistochemistry.
Chien CY; Tai CF; Ho KY; Kuo WR; Chai CY; Hsu YC; Wang LF
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):206-10. PubMed ID: 18656716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
